Loading...
Marketed drugs used for the management of hypercholesterolemia as anticancer armament
The design of novel pharmacologic agents as well as their approval for sale in markets all over the world is a tedious and pricey process. Inevitably, oncologic patients commonly experience unwanted effects of new anticancer drugs, while the acquisition of clinical experience for these drugs is larg...
Na minha lista:
| Udgivet i: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5598753/ https://ncbi.nlm.nih.gov/pubmed/28932124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S140483 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|